Camber Pharmaceuticals recalls Lacosamide Oral Solution due to p-Hydroxybenzoic Acid content failing excipient specifications. This affects prescription 200mL bottles manufactured in 2024. No remedy specified in official notice.
“Camber Lacosamide Oral Solution Recall: Failed Excipient Specifications.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34196-camber-lacosamide-oral-solution-recall-failed-excipient-specifications. Based on FDA recall #D-0094-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0094-2023%22&limit=1).
The FDA announced on Dec. 6, 2022, that Camber Pharmaceuticals Inc. voluntarily recalled Lacosamide Oral Solution due to failed excipient specifications. The recall affects products distributed nationwide.
The recall was initiated because an out-of-specification result was observed for p-Hydroxybenzoic Acid content. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Camber Pharmaceuticals Inc. has two other recalls on record since Feb. 28, 2019. On March 13, 2023, the company recalled Atovaquone Oral Suspension due to microbial contamination risk. Other recent recalls of similar products include Harvard Drug Group Omega-3 Capsules Recall (April 9, 2026), Sagent Busulfan Injection Recall (May 4, 2026), and Cipla Phytonadione Injectable Emulsion Recall (Oct. 31, 2025).
How to tell if you have this one
Check for Lacosamide Oral Solution 10mg/mL in 200mL bottles with NDC 31722-627-26. Look for lot numbers E222200, E222199 (expiring May 2024) or E222228 (expiring June 2024).
Brand
Camber
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Identify the lot number and expiration date on the bottle label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class III
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0094-2023 (December 6, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0094-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.